Diabetic Treatment Centers of America, Inc. Announces The Hiring Of Dr. Sherman B. Johnson, M.D.

SALT LAKE CITY, Oct. 25 /PRNewswire-FirstCall/ -- Diabetic Treatment Centers of America, Inc. (BULLETIN BOARD: DBTC) today announced the hiring of Dr. Sherman B. Johnson, M.D. Dr. Johnson will oversee all medical aspects of clinic operations. In addition, Dr. Johnson will evaluate all new therapies as they become available, and determine the value of those therapies to our patients.

“Dr. Johnson is a key addition to our management team. His years of experience will provide knowledge and guidance as we grow our network of clinics,” said Arden Oliphant, CEO Diabetic Treatment Centers of America, Inc.

“I am very excited to be a part of the Diabetic Treatment Centers of America team. Our PIT therapy will greatly improve the lives of many people suffering from the difficulties brought on by severe diabetes,” said Dr. Johnson.

Dr. Johnson completed his undergraduate studies at Utah State University and received his M.D. from the University of Utah, School of Medicine. He interned at the University Hospital at UC San Diego, and was a resident at the David Grant United States Air Force Medical Center, UC Davis.

About Diabetic Treatment Centers of America

Based in Salt Lake City, Utah, DTC of America is dedicated to providing diabetics with significantly improved health and a better quality of life.

Safe Harbor Statement

This news release may include forward-looking statements within the meaning of Section 27a of the United States Securities Act of 1933, as amended, and Section 21e of the United States Securities and Exchange Act of 1934, as amended, with respect to achieving corporate objectives, developing additional project interests, the company’s analysis of opportunities in the acquisition and development of various project interests and certain other matters. These statements are made under the “Safe Harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 and involve risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements contained herein.

Diabetic Treatment Centers of America, Inc. Arden Oliphant, 801-207-1816 aoliphant@dtcofamerica.com

Diabetic Treatment Centers of America, Inc.

CONTACT: Arden Oliphant of Diabetic Treatment Centers of America, Inc.,+1-801-207-1816, aoliphant@dtcofamerica.com